Advertisement

Occupational Rhinitis: Classification, Diagnosis, and Therapeutics

  • Zhisheng Shao
  • Jonathan A. BernsteinEmail author
Occupational Allergies (JA Poole, Section Editor)
First Online:
  • 37 Downloads
Part of the following topical collections:
  1. Topical Collection on Occupational Allergies

Abstract

Purpose of Review

Occupational rhinitis (OR), an inflammatory disease of the nose, refers to any nasal symptoms reported to be work-related. The purpose of this review is to provide a current overview of the classification, diagnosis, and treatment of OR.

Recent Findings

Occupational rhinitis (OR) can further be classified into allergic or non-allergic depending on the causative agent(s) and pathogenesis. Presenting symptoms are similar to non-OR including nasal congestion, anterior and posterior rhinorrhea, sneezing, and nasal itching. Despite its high prevalence in a spectrum of workplaces, OR is under reported as it is often considered a nuisance rather than a potential precursor to occupational asthma (OA). The diagnosis of OR is obfuscated as it is difficult to determine if this condition was caused by environmental determinants in or outside the workplace. Furthermore, workers may have a pre-existing history of allergic or non-allergic rhinitis leading the clinician and worker to overlook inciting agents in the workplace. In this case, a diagnosis of OR is still possible depending on the exposures but must be differentiated from work-exacerbated rhinitis. Further complicating the diagnosis of OR is the lack of evidence-based research focused on this condition as it is often trivialized due to the perception that it has an insignificant impact on the worker’s health. The reality is that OR can have a significant impact on the worker’s quality of life and is associated with a number of comorbidities including occupational asthma, recurrent sinusitis, headaches, eustachian tube dysfunction, and sleep disorders similar to non-occupational rhinitis. However, one significant difference between these disorders is that workers diagnosed with OR are eligible for worker’s compensation. Treatment of OR involves avoidance of the inciting agent(s) and medications similar to those used to treat non-OR conditions.

Summary

This review summarizes recent progresses on the etiology, risk factors, diagnosis, and therapy of OR. In addition, suggested areas of further research with potential targets for modifications in the workplace environment as well as therapeutic interventions will be discussed.

Keywords

Occupational rhinitis Workplace rhinitis IgE Rhinitis Inflammatory disease 

Abbreviations

OR

Occupational rhinitis

OA

Occupational asthma

This is a preview of subscription content, log in to check access.

Notes

Compliance with Ethical Standards

Conflict of Interest

The authors declare no conflicts of interest relevant to this manuscript.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    • EAACI Task Force on Occupational Rhinitis, Moscato G, Vandenplas O, Gerth Van Wijk R, Malo JL, Quirce S, et al. Occupational rhinitis. Allergy. 2008;63:969–80 This is a nice review of occupational rhinitis. CrossRefGoogle Scholar
  2. 2.
    •• Moscato G, Siracusa A. Rhinitis guidelines and implications for occupational rhinitis. Curr Opin Allergy Clin Immunol. 2009;9:110–5 This article is a consensus guideline on the classification, diagnosis, and treatment of OR. CrossRefGoogle Scholar
  3. 3.
    Vandenplas O. Asthma and rhinitis in the workplace. Curr Allergy Asthma Rep. 2010;10:373–80.CrossRefGoogle Scholar
  4. 4.
    Sublett JW, Bernstein DI. Occupational rhinitis. Immunol Allergy Clin N Am. 2011;31:787–96 vii.CrossRefGoogle Scholar
  5. 5.
    Hellgren J, Toren K. Nonallergic occupational rhinitis. Clin Allergy Immunol. 2007;19:241–8.PubMedGoogle Scholar
  6. 6.
    Castano R, Malo JL. Occupational rhinitis and asthma: where do we stand, where do we go? Curr Allergy Asthma Rep. 2010;10:135–42.CrossRefGoogle Scholar
  7. 7.
    Drake-Lee A, Ruckley R, Parker A. Occupational rhinitis: a poorly diagnosed condition. J Laryngol Otol. 2002;116:580–5.CrossRefGoogle Scholar
  8. 8.
    • Stevens WW, Grammer LC 3rd. Occupational rhinitis: an update. Curr Allergy Asthma Rep. 2015;15:487 This is a more recent review on OR. Google Scholar
  9. 9.
    •• Bernstein JA, Bernstein IL. A novel case of mealworm-induced occupational rhinitis in a school teacher. Allergy Asthma Proc. 2002;23:41–4 This is a very nice case report illustrating how to evaluate, characterize, and diagnose a patient with suspected OR. PubMedGoogle Scholar
  10. 10.
    •• Grammer LC 3rd. Occupational rhinitis. Immunol Allergy Clin N Am. 2016;36:333–41 This is a more recent review of OR. CrossRefGoogle Scholar
  11. 11.
    Hytonen M, Kanerva L, Malmberg H, Martikainen R, Mutanen P, Toikkanen J. The risk of occupational rhinitis. Int Arch Occup Environ Health. 1997;69:487–90.CrossRefGoogle Scholar
  12. 12.
    Nielsen GD, Olsen O, Larsen ST, Lovik M, Poulsen LK, Glue C, et al. IgE-mediated sensitisation, rhinitis and asthma from occupational exposures. Smoking as a model for airborne adjuvants? Toxicology. 2005;216:87–105.CrossRefGoogle Scholar
  13. 13.
    Siracusa A, Marabini A, Folletti I, Moscato G. Smoking and occupational asthma. Clin Exp Allergy. 2006;36:577–84.CrossRefGoogle Scholar
  14. 14.
    Ballal SG. Occupational rhinitis revisited: emphasis on the risk factors in Saudi industry. Saudi J Med Sci. 2016;4:154–63.CrossRefGoogle Scholar
  15. 15.
    Dantas Ide P, Valera FC, Zappelini CE, Anselmo-Lima WT. Prevalence of rhinitis symptoms among textile industry workers exposed to cotton dust. Int Arch Otorhinolaryngol. 2013;17:26–30.PubMedGoogle Scholar
  16. 16.
    Moscato G, Pignatti P, Yacoub MR, Romano C, Spezia S, Perfetti L. Occupational asthma and occupational rhinitis in hairdressers. Chest. 2005;128:3590–8.CrossRefGoogle Scholar
  17. 17.
    •• Maoua M, Maalel OE, Kacem I, Guedri S, Ben Kacem M, Aissa S, et al. Quality of life and work productivity impairment of patients with allergic occupational rhinitis. Tanaffos. 2019;18:58–65 This is a recent study illustrating the impact OR has on worker productivity and quality of life. PubMedPubMedCentralGoogle Scholar
  18. 18.
    Slavin RG. The allergist and the workplace: occupational asthma and rhinitis. Allergy Asthma Proc. 2005;26:255–61.PubMedGoogle Scholar
  19. 19.
    Slavin RG. Update on occupational rhinitis and asthma. Allergy Asthma Proc. 2010;31:437–43.CrossRefGoogle Scholar
  20. 20.
    Merget R, Kulzer R, Dierkes-Globisch A, Breitstadt R, Gebler A, Kniffka A, et al. Exposure-effect relationship of platinum salt allergy in a catalyst production plant: conclusions from a 5-year prospective cohort study. J Allergy Clin Immunol. 2000;105:364–70.CrossRefGoogle Scholar
  21. 21.
    Gorski P, Krakowiak A, Pazdrak K, Palczynski C, Ruta U, Walusiak J. Nasal challenge test in the diagnosis of allergic respiratory diseases in subjects occupationally exposed to a high molecular allergen (flour). Occup Med (Lond). 1998;48:91–7.CrossRefGoogle Scholar
  22. 22.
    Grammer LC, Ditto AM, Tripathi A, Harris KE. Prevalence and onset of rhinitis and conjunctivitis in subjects with occupational asthma caused by trimellitic anhydride (TMA). J Occup Environ Med. 2002;44:1179–81.CrossRefGoogle Scholar
  23. 23.
    Hisinger-Molkanen H, Piirila P, Haahtela T, Sovijarvi A, Pallasaho P. Smoking, environmental tobacco smoke and occupational irritants increase the risk of chronic rhinitis. World Allergy Organ J. 2018;11:6.CrossRefGoogle Scholar
  24. 24.
    Tantilipikorn P, Vichyanond P, Lacroix JS. Nasal provocation test: how to maximize its clinical use? Asian Pac J Allergy Immunol. 2010;28:225–31.PubMedGoogle Scholar
  25. 25.
    •• Castano R, Trudeau C, Castellanos L, Malo JL. Prospective outcome assessment of occupational rhinitis after removal from exposure. J Occup Environ Med. 2013;55:579–85 This study illustrates the impact of avoidance in resolving OR. CrossRefGoogle Scholar
  26. 26.
    Gerth van Wijk R, Patiwael JA, de Jong NW, de Groot H, Burdorf A. Occupational rhinitis in bell pepper greenhouse workers: determinants of leaving work and the effects of subsequent allergen avoidance on health-related quality of life. Allergy. 2011;66:903–8.CrossRefGoogle Scholar
  27. 27.
    Gautrin D, Desrosiers M, Castano R. Occupational rhinitis. Curr Opin Allergy Clin Immunol. 2006;6:77–84.PubMedGoogle Scholar
  28. 28.
    Hellgren J, Karlsson G, Toren K. The dilemma of occupational rhinitis: management options. Am J Respir Med. 2003;2:333–41.CrossRefGoogle Scholar
  29. 29.
    Bernstein DI, Schwartz G, Bernstein JA. Allergic rhinitis: mechanisms and treatment. Immunol Allergy Clin N Am. 2016;36:261–78.CrossRefGoogle Scholar
  30. 30.
    Carr W, Bernstein J, Lieberman P, Meltzer E, Bachert C, Price D, et al. A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis. J Allergy Clin Immunol. 2012;129:1282–9 e10.CrossRefGoogle Scholar
  31. 31.
    •• Greiwe JC, Bernstein JA. Combination therapy in allergic rhinitis: what works and what does not work. Am J Rhinol Allergy. 2016;30:391–6 This article provides a nice overview of the treatment of allergic rhinitis which would also apply to OR. CrossRefGoogle Scholar
  32. 32.
    Hampel FC, Ratner PH, Van Bavel J, Amar NJ, Daftary P, Wheeler W, et al. Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device. Ann Allergy Asthma Immunol. 2010;105:168–73.CrossRefGoogle Scholar
  33. 33.
    Meltzer EO, LaForce C, Ratner P, Price D, Ginsberg D, Carr W. MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial of efficacy and safety. Allergy Asthma Proc. 2012;33:324–32.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.School of Podiatric MedicineTemple UniversityPhiladelphiaUSA
  2. 2.Bernstein Allergy GroupCincinnatiUSA
  3. 3.Division of Immunology, Allergy and Rheumatology, Department of Internal MedicineUniversity of CincinnatiCincinnatiUSA

Personalised recommendations

Cite article

Buy options